{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:19:53Z","timestamp":1791170393687,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.drugalcdep.2007.09.019","type":"journal-article","created":{"date-parts":[[2007,12,13]],"date-time":"2007-12-13T15:57:50Z","timestamp":1197561470000},"page":"207-215","source":"Crossref","is-referenced-by-count":22,"title":["Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats"],"prefix":"10.1016","volume":"97","author":[{"given":"Xiao-Qing","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Veeraraghavan","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin D.","family":"Gagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debarshi","family":"Pratihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles R.","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot L.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2007.09.019_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1360-0443.2005.00983.x","article-title":"A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence","volume":"100","author":"Berger","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","article-title":"A randomized placebo-controlled trial of gabapentin for cocaine dependence","volume":"81","author":"Bisaga","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0166-4328(03)00110-4","article-title":"Reinforcing versus anticonvulsant drugs: effects on intracranial self-stimulation rate-frequency M50 indices","volume":"144","author":"Bossert","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/syn.10278","article-title":"Treating cocaine addiction: from preclinical to clinical trial experience with \u03b3-vinyl GABA","volume":"50","author":"Brodie","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib5","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1523\/JNEUROSCI.14-11-06763.1994","article-title":"Cocaine inhibits GABA release in the VTA through endogenous 5-HT","volume":"14","author":"Cameron","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002130050937","article-title":"Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats","volume":"143","author":"Campbell","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib7","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1523\/JNEUROSCI.16-09-03112.1996","article-title":"Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex","volume":"16","author":"Carlezon","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W","article-title":"GABAergic attenuation of cocaine-induced dopamine release and locomotor activity","volume":"25","author":"Dewey","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F","article-title":"A novel strategy for the treatment of cocaine addiction","volume":"30","author":"Dewey","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.npp.1300088","article-title":"The GABAB receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats","volume":"28","author":"Di Ciano","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.bjp.0702794","article-title":"Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs","volume":"128","author":"Eckstein-Ludwig","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.05.011","article-title":"Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization","volume":"541","author":"Filip","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-006-0694-7","article-title":"Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats","volume":"192","author":"Filip","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/105504900750047355","article-title":"What we have learned about addiction from animal models of drug self-administration","volume":"9","author":"Gardner","year":"2000","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(24)35017-7","article-title":"Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures","volume":"290","author":"Gasior","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-3565(24)37763-8","article-title":"Imidazenil, a positive allosteric GABAA receptor modulator, inhibits the effects of cocaine on locomotor activity and extracellular dopamine in the nucleus accumbens shell without tolerance liability","volume":"287","author":"Giorgetti","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00003495-199346030-00007","article-title":"Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy","volume":"46","author":"Goa","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.07.003","article-title":"Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients","volume":"87","author":"Gonz\u00e1lez","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1360-0443.2003.00544.x","article-title":"Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study","volume":"98","author":"Gonz\u00e1lez","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","article-title":"Agents in development for the management of cocaine abuse","volume":"64","author":"Gorelick","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib21","first-page":"636","article-title":"Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum","volume":"43","author":"G\u00f6tz","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00004714-200006000-00003","article-title":"Risperidone for the treatment of cocaine dependence: randomized, double-blind trial","volume":"20","author":"Grabowski","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugalcdep.2005.03.006","article-title":"Smoked cocaine discrimination in humans: effects of gabapentin","volume":"80","author":"Haney","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002130100725","article-title":"Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2006.05.028","article-title":"Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses","volume":"86","author":"Hart","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2003.10.015","article-title":"Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans","volume":"73","author":"Hart","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib27","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1523\/JNEUROSCI.15-09-06287.1995","article-title":"The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons","volume":"15","author":"Henry","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(95)00634-3","article-title":"The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis","volume":"692","author":"Honmou","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s002130000394","article-title":"Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice","volume":"151","author":"Itzhak","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00023210-200519100-00005","article-title":"Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function","volume":"19","author":"Johnson","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib32","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1046\/j.1460-9568.2000.00066.x","article-title":"Dopamine-independent action of cocaine on striatal and accumbal neurons","volume":"12","author":"Kiyatkin","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s002130050418","article-title":"Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds","volume":"133","author":"Kushner","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-3565(24)34966-3","article-title":"The irreversible \u03b3-aminobutyric acid (GABA) transaminase inhibitor \u03b3-vinyl-GABA blocks cocaine self-administration in rats","volume":"290","author":"Kushner","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib35","series-title":"Abstracts of the 68th Annual Scientific Meeting of the College on Problems of Drug Dependence, 2006","article-title":"Gabapentin has no effect on cocaine-primed relapse and cocaine-induced increases in dopamine in the nucleus accumbens","author":"Li","year":"2006"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0304-3940(91)90249-S","article-title":"Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain","volume":"128","author":"L\u00f6scher","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004714-199710000-00012","article-title":"Gabapentin abuse in a cocaine user: implications for treatment?","volume":"17","author":"Markowitz","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib38","article-title":"Gabapentin and postoperative pain; a qualitative and quantitative systematic review, with focus on procedure","volume":"7:6","author":"Mathiesen","year":"2007","journal-title":"BMC Anesthesiol."},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2007.09.019_bib39","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1111\/j.1528-1157.1999.tb00921.x","article-title":"Gabapentin","volume":"40","author":"Morris","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.v62n0105","article-title":"Gabapentin in the treatment of cocaine dependence: a case series","volume":"62","author":"Myrick","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s002130100724","article-title":"Repeated administration of the D1\/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine","volume":"155","author":"Nann-Vernotica","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib42","series-title":"Abstracts of the 34th Annual Meeting of the Society for Neuroscience, 2004","article-title":"Gamma-vinyl GABA, but not gabapentin, inhibits cocaine-triggered reinstatement of drug-seeking behavior in the rat","author":"Peng","year":"2004"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neulet.2007.04.021","article-title":"Study pharmacologic of the GABAergic and glutamatergic drugs on seizures and status epilepticus induced by pilocarpine in adult Wistar rats","volume":"419","author":"Pereira","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib44","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1176\/appi.ajp.157.12.2058-a","article-title":"Gabapentin therapy for cocaine cravings","volume":"157","author":"Raby","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4088\/JCP.v65n0114","article-title":"Gabapentin reduces cocaine use among addicts from a community clinic sample","volume":"65","author":"Raby","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/10550490490460300","article-title":"Gabapentin abuse in inmates with prior history of cocaine dependence","volume":"13","author":"Reccoppa","year":"2004","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.physbeh.2005.06.017","article-title":"Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction","volume":"86","author":"Roberts","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0893-133X(96)00002-4","article-title":"Baclofen attenuates the reinforcing effects of cocaine in rats","volume":"15","author":"Roberts","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-003-1446-6","article-title":"Sub-chronic low dose \u03b3-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine","volume":"168","author":"Schiffer","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4088\/JCP.v64n1207","article-title":"Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use","volume":"64","author":"Shoptaw","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0922-4106(93)90155-3","article-title":"Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies","volume":"244","author":"Suman-Chauhan","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.expneurol.2006.06.002","article-title":"Gabapentin depresses C-fiber-evoked field potentials in rat spinal dorsal horn only after induction of long-term potentiation","volume":"202","author":"Tanabe","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(97)00084-3","article-title":"Summary of mechanistic hypotheses of gabapentin pharmacology","volume":"29","author":"Taylor","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(00)00309-5","article-title":"A microdialysis study on the mechanism of action of gabapentin","volume":"398","author":"Timmerman","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib56","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2005. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. http:\/\/www.fda.gov\/cder\/guidance\/index.htm. (accessed on October 19, 2007)."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1023\/A:1016092525901","article-title":"The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using microdialysis-pharmacokinetic approach","volume":"13","author":"Wang","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(96)80079-1","article-title":"Neurobiology of addiction","volume":"6","author":"Wise","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib59","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/j.1460-9568.2005.04159.x","article-title":"Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost \u2013 variable-payoff fixed-ratio cocaine self-administration in rats","volume":"21","author":"Xi","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.019_bib60","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1523\/JNEUROSCI.0726-06.2006","article-title":"Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens","volume":"26","author":"Xi","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607004115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607004115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T17:24:39Z","timestamp":1737653079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871607004115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0376871607004115"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.09.019","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}